Search results
Nonproprietary (generic) names. History. List of stems and affixes. Example breakdown of a drug name. Combination drug products. Pronunciation. Drug brands Name. Publication policies for nonproprietary and proprietary names. Examples. See also. References. Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs.
Sep 12, 2013 · Non-proprietary name is the name for the active ingredient in the medicine that is decided by an expert committee and is understood internationally (WHO, 2013a ). Thus, paracetamol/acetaminophen is the non-proprietary name (generic name) while Crocin/Metacin/Meftal/Tylenol etc. are brand names.
- Karan B. Thakkar, Gauri Billa
- 2013
As of January, 2021, several mRNA-based vaccines and one plasmid-based DNA vaccine have been assigned INNs, including the anti-rabies mRNA nadorameran, the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNAs zorecimeran4 and tozinameran, and the anti-SARS-CoV-2 DNA plasmid reluscovtogene ralaplasmid.
When the WHO accepts a name, it’s published on a proposed International Nonproprietary Names (INN) list, and, over the course of four months, the public can come forward and object to the name. If no one objects, it publishes to a recommended INN list and Pfizer can start referring to the drug by the nonproprietary name, rather than by code.
International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.
Feb 21, 2023 · After a chemical name is established, the generic name comes next. The USAN Council, the WHO’s International Nonproprietary Names (INN) expert group, and a medication’s manufacturer must agree on a generic name. The generic name selection process typically occurs in early phases of clinical trials.
Apr 13, 2021 · The World Health Organization assigns international nonproprietary names (INN), also known as common names, to compounds upon request from drug developers. Structures of INNs are publicly available and represent a source, albeit underused, to understand trends in drug research and development.
